Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yuqiong Xie"'
Autor:
Wenjing Chen, Shikun Xiao, Yi Liu, Xiaowu Hu, Yuqiong Xie, Yichi Liu, Yan Ma, Lixiang Luo, Xiongxin Jiang
Publikováno v:
Journal of Materials Research and Technology, Vol 27, Iss , Pp 1857-1873 (2023)
Energy storage technology based on phase change materials (PCM) can effectively solve the problem of poor energy utilization. However, PCM suffer from problems such as low thermal conductivity and easy leakage, which seriously hinder their applicatio
Externí odkaz:
https://doaj.org/article/dfb4fc312f234e72977fbd8090df6353
Autor:
Maoxiao Yan, Jia Chen, Hua Jiang, Yuqiong Xie, Chunchun Li, Lihong Chen, Beibei Yang, Jiang Cao
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237098 (2020)
The EGFR-targeting cancer therapies are commonly facing drug resistance, mostly due to mutations. Gene therapy with artificial microRNA targeting EGFR conserved sequence may avoid such problem. In this study, we constructed a recombinant adenovirus e
Externí odkaz:
https://doaj.org/article/0ce7c9bb3dc44514a7b93c6507fc1606
Publikováno v:
Zhongguo quanke yixue, Vol 26, Iss 05, Pp 550-556 (2023)
Background Respiratory virus infection is an important trigger of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) . China has adopted a series of containment measures assisting to curb COVID-19 transmission since the outbreak of
Externí odkaz:
https://doaj.org/article/af4d272897df4e74ba86d95771df9113
Publikováno v:
Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 38(3)
ERα-36 is a novel subtype of estrogen receptor α which promotes tumor cell proliferation, invasion and drug resistance, and it serves as a therapeutic target. However, only small-molecule compounds targeting ERα-36 are under development as antican
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afc3f492d12bbc4067169ad2cb57c4f9
https://pubmed.ncbi.nlm.nih.gov/35355476
https://pubmed.ncbi.nlm.nih.gov/35355476
Autor:
Shikun Xiao, Minming Zou, Yuqiong Xie, Wenjing Chen, Xiaowu Hu, Yan Ma, Shuai Zu, Yinhui Che, Xiongxin Jiang
Publikováno v:
Journal of Energy Storage. 56:105976
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d919716c3f016a63efb321ab48e3945
https://doi.org/10.1016/j.est.2022.105976
https://doi.org/10.1016/j.est.2022.105976
Publikováno v:
Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 36(5)
Drugs targeting immune checkpoint are used for cancer treatment, but resistance to single drug may occur. Combination therapy blocking multiple checkpoints simultaneously can improve clinical outcome. Therefore, we designed a recombinant protein rPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18793552bccddc0eeed1195708f93ae0
https://pubmed.ncbi.nlm.nih.gov/32567280
https://pubmed.ncbi.nlm.nih.gov/32567280
Autor:
Chunchun Li, Yuqiong Xie, Hua Jiang, Jia Chen, Jiang Cao, Maoxiao Yan, Beibei Yang, Lihong Chen
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237098 (2020)
PLoS ONE
PLoS ONE
The EGFR-targeting cancer therapies are commonly facing drug resistance, mostly due to mutations. Gene therapy with artificial microRNA targeting EGFR conserved sequence may avoid such problem. In this study, we constructed a recombinant adenovirus e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c58e16516bc41b375ae98936eb15c0a7
https://doi.org/10.1371/journal.pone.0237098
https://doi.org/10.1371/journal.pone.0237098
Autor:
Yuqiong Xie1,2, Qiang Li1,2, Qingbo Yang1, Mei Yang1,2, Zhifeng Zhang1, Liucun Zhu2, Huang Yan1, Ruili Feng1, Shiqing Zhang1,2, Chen Huang1, Zengrong Liu2, Tieqiao Wen1,2 wtq@shu.edu.cn
Publikováno v:
Scientific Reports. 1/17/2014, p1-7. 7p.
Publikováno v:
Oncotarget
// Yuqiong Xie 1, * , Chunchun Li 1, * , Yali Huang 2 , Zhenyu Jia 3 and Jiang Cao 1 1 Clinical Research Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China 2 Institute of Hygiene, Zhejiang Academy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b0810caf91a1d291591eefbc0cd0aa
https://pubmed.ncbi.nlm.nih.gov/29152075
https://pubmed.ncbi.nlm.nih.gov/29152075
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 32(5)
To establish the human colorectal cancer cell model SW620/PAR4D with inducible suppression of proteinase activated receptor 4 (PAR4) expression, and investigate the role PAR4 plays in the proliferation and migration of cancer cells.A human colorectal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67a56bfdf408633e29f14cd78bb9dd7f
https://pubmed.ncbi.nlm.nih.gov/27126938
https://pubmed.ncbi.nlm.nih.gov/27126938